Oragenics, Inc. 0A64.L Stock
Oragenics, Inc. Price Chart
Oragenics, Inc. 0A64.L Financial and Trading Overview
| Oragenics, Inc. stock price | 1.02 USD |
| Previous Close | 2.97 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 23.4 USD |
| Volume | 560 USD |
| Avg. Volume | 95 USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.336267 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.142 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0A64.L Valuation Measures
| Enterprise Value | -1265804 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6802715 |
| Enterprise Value/Revenue | -9.484 |
| Enterprise Value/EBITDA | 0.1 |
Trading Information
Oragenics, Inc. Stock Price History
| Beta (5Y Monthly) | 0.336267 |
| 52-Week Change | -82.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 23.4 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 10.42 USD |
| 200-Day Moving Average | 11 USD |
0A64.L Share Statistics
| Avg. Volume (3 month) | 95 USD |
| Avg. Daily Volume (10-Days) | 95 USD |
| Shares Outstanding | N/A |
| Float | 1.99M |
| Short Ratio | N/A |
| % Held by Insiders | 1.96% |
| % Held by Institutions | 7.38% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.016667:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -9527.030% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.29% |
| Return on Equity (ttm) | -81.48% |
Income Statement
| Revenue (ttm) | 133.46K USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | 12.90% |
| Gross Profit (ttm) | -9941163 USD |
| EBITDA | -12667464 USD |
| Net Income Avi to Common (ttm) | -12542233 USD |
| Diluted EPS (ttm) | -0.142 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.16M USD |
| Total Cash Per Share (mrq) | 4.52 USD |
| Total Debt (mrq) | 414.54K USD |
| Total Debt/Equity (mrq) | 4.05 USD |
| Current Ratio (mrq) | 6.573 |
| Book Value Per Share (mrq) | 4.273 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11700226 USD |
| Levered Free Cash Flow (ttm) | -9108191 USD |
Profile of Oragenics, Inc.
| Country | United Kingdom |
| State | FL |
| City | Tampa |
| Address | 4902 Eisenhower Boulevard |
| ZIP | 33634 |
| Phone | 813 286 7900 |
| Website | https://www.oragenics.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 6 |
Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.
Q&A For Oragenics, Inc. Stock
What is a current 0A64.L stock price?
Oragenics, Inc. 0A64.L stock price today per share is 1.02 USD.
How to purchase Oragenics, Inc. stock?
You can buy 0A64.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oragenics, Inc.?
The stock symbol or ticker of Oragenics, Inc. is 0A64.L.
How many shares does Oragenics, Inc. have in circulation?
The max supply of Oragenics, Inc. shares is 0.
What is Oragenics, Inc. Price to Earnings Ratio (PE Ratio)?
Oragenics, Inc. PE Ratio is now.
What was Oragenics, Inc. earnings per share over the trailing 12 months (TTM)?
Oragenics, Inc. EPS is -0.142 USD over the trailing 12 months.